|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.08 EUR | -1.64% |
|
+1.89% | -1.64% |
| Mar. 19 | Bioera tops post-accounts; goes down Restart | AN |
| Mar. 15 | Giuliano Ferrari buys 20,000 shares in Emak | AN |
Emak S.p.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 605.72 million compared to EUR 588.3 million a year ago. Net income was EUR 30.27 million compared to EUR 32.51 million a year ago.
Basic earnings per share from continuing operations was EUR 0.185 compared to EUR 0.199 a year ago. Diluted earnings per share from continuing operations was EUR 0.185 compared to EUR 0.199 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.64% | 188M | |
| -1.64% | 109B | |
| -8.84% | 9.14B | |
| +10.34% | 4.35B | |
| +27.11% | 2.79B | |
| +64.52% | 2.27B | |
| -10.00% | 1.28B | |
| +18.94% | 834M | |
| +102.98% | 603M | |
| +39.37% | 546M |
EMAK S.P.A. 
